Showing results (1431-1440 of 1,540) with videos related to
Sort By:
Pageof 154
ESMO Open|November 29, 2021
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neckB Keam, J-P Machiels, H R Kim, et al.Nature Metabolism|August 20, 2019
Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetesErcument Dirice, Sevim Kahraman, Dario F De Jesus, et al.Molecular Genetics & Genomic Medicine|May 1, 2020
The KLHL40 c.1516A>C is a Chinese-specific founder mutation causing nemaline myopathy 8: Report of six patients with pre- and postnatal phenotypesKit San Yeung, Florrie N Y Yu, Cheuk Wing Fung, et al.Nature Cancer|January 4, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotypingEvan W Warner, Kim Van der Eecken, Andrew J Murtha, et al.Clinical & Translational Immunology|February 28, 2018
Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infectionSusanna S Ng, Fernando Souza-Fonseca-Guimaraes, Fabian de Labastida Rivera, et al.Nature Biotechnology|November 8, 2016
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephrosElizabeth S Ng, Lisa Azzola, Freya F Bruveris, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2020
Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver MutationsMarcelo V Negrao, Victoria M Raymond, Richard B Lanman, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 19, 2023
The structural and social determinants of Alzheimer's disease related dementiasParis B Adkins-Jackson, Kristen M George, Lilah M Besser, et al.Pageof 154